PHS
APTV icon

PFM Health Sciences’s Aptiv APTV Stock Holding History

PFM Health Sciences’s Portfolio APTV Stock Details APTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,794
Closed -$13.8M – 88
2020
Q3 		$13.8M Buy
150,794
+13,037
+9% +$1.09M 0.64% 53
2020
Q2 		$10.7M Buy
+137,757
New +$9.48M 0.56% 57
2019
Q2 		– Sell
-391,418
Closed -$31.1M – 88
2019
Q1 		$31.1M Buy
+391,418
New +$30.1M 0.69% 53

Other funds holding APTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

PFM Health Sciences's APTV Position: Q4 2020 in Review

PFM Health Sciences sold out of Aptiv (APTV) in Q4 2020, closing a stake of 150,794 shares — an estimated $13.8M sold.

PFM Health Sciences first reported a position in APTV in Q1 2019 and held it in 3 quarters. The position peaked at $31.1M in Q1 2019. 673 funds tracked by Wall St. Rank hold APTV as of Q4 2020.

  • PFM Health Sciences reported no remaining Aptiv position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 150,794 Aptiv shares in Q4 2020, an estimated $13.8M.
  • PFM Health Sciences first reported a position in Aptiv in Q1 2019 and held it in 3 quarters.
  • PFM Health Sciences's Aptiv position peaked at $31.1M in Q1 2019.
  • 673 funds tracked by Wall St. Rank held Aptiv as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.